Logo image of ECAT

BLACKROCK ESG CAP ALL TRM TR (ECAT) Stock Price, Quote, News and Overview

NYSE:ECAT - New York Stock Exchange, Inc. - US09262F1003 - Currency: USD

15.18  +0.13 (+0.86%)

Fundamental Rating

2

ECAT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of ECAT have multiple concerns. ECAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ECAT was profitable.
In the past year ECAT had a positive cash flow from operations.
ECAT Yearly Net Income VS EBIT VS OCF VS FCFECAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -500M -1B -1.5B -2B

1.2 Ratios

Industry RankSector Rank
ROA 14.91%
ROE 16.04%
ROIC 1.53%
ROA(3y)1.1%
ROA(5y)N/A
ROE(3y)0.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ECAT Yearly ROA, ROE, ROICECAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 10 -10

1.3 Margins

Industry RankSector Rank
OM 60.32%
PM (TTM) 497.1%
GM 62.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ECAT Yearly Profit, Operating, Gross MarginsECAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 1K 2K

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for ECAT has been reduced compared to 1 year ago.
The debt/assets ratio for ECAT is higher compared to a year ago.
ECAT Yearly Shares OutstandingECAT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
ECAT Yearly Total Debt VS Total AssetsECAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

ECAT has an Altman-Z score of 6.43. This indicates that ECAT is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of ECAT is 0.05, which is an excellent value as it means it would take ECAT, only 0.05 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.00 indicates that ECAT is not too dependend on debt financing.
Even though the debt/equity ratio score it not favorable for ECAT, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 6.43
ROIC/WACCN/A
WACCN/A
ECAT Yearly LT Debt VS Equity VS FCFECAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1B -1B 2B -2B

2.3 Liquidity

ECAT has a Current Ratio of 0.10. This is a bad value and indicates that ECAT is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.10 indicates that ECAT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
ECAT Yearly Current Assets VS Current LiabilitesECAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

ECAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 194.59%, which is quite impressive.
Looking at the last year, ECAT shows a very strong growth in Revenue. The Revenue has grown by 38.88%.
EPS 1Y (TTM)194.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%224.77%
Revenue 1Y (TTM)38.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ECAT Yearly Revenue VS EstimatesECAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.25, the valuation of ECAT can be described as very cheap.
Compared to an average S&P500 Price/Earnings ratio of 28.87, ECAT is valued rather cheaply.
Industry RankSector Rank
PE 5.25
Fwd PE N/A
ECAT Price Earnings VS Forward Price EarningsECAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.11
EV/EBITDA N/A
ECAT Per share dataECAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 22.16%, ECAT is a good candidate for dividend investing.
ECAT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 22.16%

5.2 History

ECAT has been paying a dividend for over 5 years, so it has already some track record.
ECAT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
ECAT Yearly Dividends per shareECAT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

ECAT pays out 51.48% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP51.48%
EPS Next 2YN/A
EPS Next 3YN/A
ECAT Yearly Income VS Free CF VS DividendECAT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 0 -500M -1B -1.5B -2B
ECAT Dividend Payout.ECAT Dividend Payout, showing the Payout Ratio.ECAT Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK ESG CAP ALL TRM TR

NYSE:ECAT (4/28/2025, 8:04:00 PM)

15.18

+0.13 (+0.86%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners45.66%
Inst Owner Change0.06%
Ins Owners0.1%
Ins Owner Change86.97%
Market Cap1.51B
Analysts0
Price TargetN/A
Short Float %0.23%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield 22.16%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP51.48%
Div Incr Years3
Div Non Decr Years3
Ex-Date04-15 2025-04-15 (0.30359)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.25
Fwd PE N/A
P/S 25.42
P/FCF 9.11
P/OCF 9.11
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)2.89
EY19.04%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.67
FCFY10.98%
OCF(TTM)1.67
OCFY10.98%
SpS0.6
BVpS18.51
TBVpS18.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.91%
ROE 16.04%
ROCE 1.94%
ROIC 1.53%
ROICexc 1.53%
ROICexgc 1.55%
OM 60.32%
PM (TTM) 497.1%
GM 62.15%
FCFM 279.14%
ROA(3y)1.1%
ROA(5y)N/A
ROE(3y)0.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 39762
Cash Conversion N/A
Profit Quality 56.15%
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 6.43
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)194.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%224.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.88%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%20.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y88.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-10.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.92%
OCF growth 3YN/A
OCF growth 5YN/A